Cardioprotection in cardiovascular surgery
- PMID: 38856733
- DOI: 10.1007/s00395-024-01062-0
Cardioprotection in cardiovascular surgery
Abstract
Since the invention of cardiopulmonary bypass, cardioprotective strategies have been investigated to mitigate ischemic injury to the heart during aortic cross-clamping and reperfusion injury with cross-clamp release. With advances in cardiac surgical and percutaneous techniques and post-operative management strategies including mechanical circulatory support, cardiac surgeons are able to operate on more complex patients. Therefore, there is a growing need for improved cardioprotective strategies to optimize outcomes in these patients. This review provides an overview of the basic principles of cardioprotection in the setting of cardiac surgery, including mechanisms of cardiac injury in the context of cardiopulmonary bypass, followed by a discussion of the specific approaches to optimizing cardioprotection in cardiac surgery, including refinements in cardiopulmonary bypass and cardioplegia, ischemic conditioning, use of specific anesthetic and pharmaceutical agents, and novel mechanical circulatory support technologies. Finally, translational strategies that investigate cardioprotection in the setting of cardiac surgery will be reviewed, with a focus on promising research in the areas of cell-based and gene therapy. Advances in this area will help cardiologists and cardiac surgeons mitigate myocardial ischemic injury, improve functional post-operative recovery, and optimize clinical outcomes in patients undergoing cardiac surgery.
Keywords: Cardioprotection; Cardiopulmonary bypass; Cardiovascular surgery.
© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Does isoflurane optimize myocardial protection during cardiopulmonary bypass?J Cardiothorac Vasc Anesth. 2001 Aug;15(4):418-21. doi: 10.1053/jcan.2001.24954. J Cardiothorac Vasc Anesth. 2001. PMID: 11505342 Clinical Trial.
-
New technique of local ischemic preconditioning induction without repetitive aortic cross-clamping in cardiac surgery.J Cardiothorac Surg. 2015 Jan 22;10:9. doi: 10.1186/s13019-015-0206-0. J Cardiothorac Surg. 2015. PMID: 25608502 Free PMC article. Clinical Trial.
-
Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass.Eur J Cardiothorac Surg. 2009 Oct;36(4):657-64. doi: 10.1016/j.ejcts.2009.03.065. Epub 2009 Jun 11. Eur J Cardiothorac Surg. 2009. PMID: 19523842
-
Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection.Int J Mol Sci. 2019 Aug 16;20(16):4002. doi: 10.3390/ijms20164002. Int J Mol Sci. 2019. PMID: 31426434 Free PMC article. Review.
-
Preconditioning and postconditioning: underlying mechanisms and clinical application.Atherosclerosis. 2009 Jun;204(2):334-41. doi: 10.1016/j.atherosclerosis.2008.10.029. Epub 2008 Nov 5. Atherosclerosis. 2009. PMID: 19081095 Review.
Cited by
-
Cardioprotection strategies for anthracycline cardiotoxicity.Basic Res Cardiol. 2025 Feb;120(1):71-90. doi: 10.1007/s00395-024-01078-6. Epub 2024 Sep 9. Basic Res Cardiol. 2025. PMID: 39249555 Free PMC article. Review.
-
A Single-Surgeon Experience Transitioning to Total Arterial Revascularization.J Clin Med. 2024 Aug 16;13(16):4831. doi: 10.3390/jcm13164831. J Clin Med. 2024. PMID: 39200977 Free PMC article.
-
MAFF mitigates oxidative stress and pyroptosis in cardiopulmonary bypass-induced myocardium injury.Front Physiol. 2025 Jul 31;16:1516167. doi: 10.3389/fphys.2025.1516167. eCollection 2025. Front Physiol. 2025. PMID: 40821946 Free PMC article.
-
Signaling Pathways (TNF-α-NF-κB, TLR2-TLR4 as well as ROS-MDA) and Cardiac Damages during Cardiac Surgeries (Coronary Stenting, Permanent Pacemaker Implantations, Radiofrequency Ablations).Curr Top Med Chem. 2025;25(2):196-208. doi: 10.2174/0115680266314899240919081451. Curr Top Med Chem. 2025. PMID: 39350416
-
Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic-Ischemia/Reperfusion in Nondiabetic and Diabetic Human Coronary Arterial Endothelial Cells.J Am Coll Surg. 2025 Aug 1;241(2):118-135. doi: 10.1097/XCS.0000000000001248. Epub 2025 Jul 16. J Am Coll Surg. 2025. PMID: 39651752 Free PMC article.
References
-
- Aass T, Stangeland L, Chambers DJ, Hallström S, Rossmann C, Podesser BK, Urban M, Nesheim K, Haaverstad R, Matre K, Grong K (2017) Myocardial energy metabolism and ultrastructure with polarizing and depolarizing cardioplegia in a porcine model. Eur J Cardiothorac Surg 52:180–188. https://doi.org/10.1093/ejcts/ezx035 - DOI - PubMed - PMC
-
- Abdelshafy M, Caliskan K, Guven G, Elkoumy A, Elsherbini H, Elzomor H, Tenekecioglu E, Akin S, Soliman O (2022) Temporary right-ventricular assist devices: a systematic review. J Clin Med 11:613. https://doi.org/10.3390/jcm11030613 - DOI - PubMed - PMC
-
- Abel F, Murke F, Gaida M, Garnier N, Ochsenfarth C, Theiss C, Thielmann M, Kleinbongard P, Giebel B, Peters J, Frey UH (2020) Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol exposure. PLoS ONE 15:e0228948. https://doi.org/10.1371/journal.pone.0228948 - DOI - PubMed - PMC
-
- Ahmed HM, Khraishah H, Cho L (2018) Cardioprotective anti-hyperglycaemic medications: a review of clinical trials. Eur Heart J 39:2368–2375. https://doi.org/10.1093/eurheartj/ehx668 - DOI - PubMed
-
- Allen BS, Winkelmann JW, Hanafy H, Hartz RS, Bolling KS, Ham J, Feinstein S (1995) Retrograde cardioplegia does not adequately perfuse the right ventricle. J Thorac Cardiovasc Surg 109:1116–1124. https://doi.org/10.1016/S0022-5223(95)70195-8 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources